XML 33 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-term Obligations (Details) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2011
leases
building
squarefeet
Jun. 30, 2013
Dec. 31, 2012
Long-term Debt and Capital Lease Obligations [Abstract]      
Line of Credit Facility, Current Borrowing Capacity   $ 31,900,000  
Debt Instrument, Interest Rate, Low of Range   4.00%  
Debt Instrument, Interest Rate, High of Range   7.00%  
Number of leases (leases) 2    
Area of leased property (in square feet) 1,100,000    
Number of buildings under lease agreement (buildings) 2    
Initial term of lease agreement (in years) 15 years    
Optional term of lease agreement (in years) 10 years    
Construction in progress   421,300,000 290,700,000
Construction financing lease obligation   359,100,000 [1] 268,031,000 [1]
Change in Restricted Cash Balance as Result of Transactions   $ 31,800,000  
[1] Amounts include the assets and liabilities of Vertex’s variable interest entity (“VIE”), Alios BioPharma, Inc. (“Alios”). Vertex’s interests and obligations with respect to the VIE’s assets and liabilities are limited to those accorded to Vertex in its agreement with Alios. See Note C, "Collaborative Arrangements," to these condensed consolidated financial statements for amounts.